Question
108. Correct statements for the IUPAC nomenclatures of the drugs are? I. Thiamylal: 5-(Pentan-2-yl)-5-(prop-2-en-1-yl)-2-sulfanylidenedihydropyrimidine-4,6(1H,5H)-dione. II, Secobarbital: 5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione III. Quazepam: 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione IV. Triazolam: 5-Ethyl-5-phenyl-1,3-diazinane-2,4,6-trione a) II,
108. Correct statements for the IUPAC nomenclatures of the drugs are?
I. Thiamylal: 5-(Pentan-2-yl)-5-(prop-2-en-1-yl)-2-sulfanylidenedihydropyrimidine-4,6(1H,5H)-dione.
II, Secobarbital: 5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione
III. Quazepam: 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
IV. Triazolam: 5-Ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
a) II, III
b) II, IV
c) I, II, IV
d) I, II
109. Match the following drugs with their correct classificationsi.
Thiamylal A. Barbiturate sedative-hypnotic
ii. Zolpidem B.Benzazepine
iii. Olanzapine C. Nonbenzodiazepine agonist
iv. Oxazepam D. Benzodiazepine
a) i-A, ii-C, iii-B, iv-D
b) i-B, ii-D, iii-A, iv-C
c) i-A, ii-D, iii-C, iv-B
d) i-C, ii-A, iii-B, iv-D
110. Binding of Chlordiazepoxide with acetylcholine muscarinic receptors results in?
a) Agonizing effect on muscarinic receptors
b) Antagonizing effect on muscarinic receptors
c) Do not produce any significant effect
d) Do not bind with muscarinic receptor
111. Therapeutic use of drug Chlordiazepoxide is/are?
a) Treatment of Acute alcohol withdrawal
b) Relieving fear
c) Treatment of anxiety
d) All of the above
112. Type of ring structures present in the structure of Chlordiazepoxide?
a) Quiniclidine
b) Quinoline
c) Diazepine
d) All of the above
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started